Future Positive Capital’s first fund is moving under the management of 2050, the evergreen investment platform founded by Marie Ekeland, as founder Sofia Hmich steps back from day-to-day fund management for private, family reasons.
The amicable transfer covers Future Positive Capital’s €63 million Fund I, a 2019-vintage fund with 15 active companies across sustainability and health. More than 90% of the fund has already been invested, with 2050 now taking responsibility for managing the portfolio, LP relationships and future follow-on and exit decisions.
The move brings 2050’s combined platform to €210 million across around 30 companies in healthcare, energy, environmental restoration and ocean conservation. Together, 2050 and Future Positive Capital’s Fund I represent 32 European and transatlantic companies.
Speaking to Pathfounders over a call, Ekeland said the deal was driven by trust, continuity and a close overlap in investment philosophy.
“There’s not that many female GPs innovating in the venture capital industry,” she said. “We’ve been following each other for many years and built a trusting relationship.”
She said Hmich had been looking for “the best solution” to preserve the work already done at Future Positive Capital and “take good care of the portfolio she’s built and the LP relationship.”
The transfer does not affect Future Positive Capital’s management company or brand, which remain with Hmich, and this will leave her the freedom to raise a fresh fund some time in the future. Hmich will retain an advisory role, stay on the board of one portfolio company and provide input to 2050 on valuations and investment decisions, though formal decision-making now sits with 2050.
Ekeland said 2050 was a natural fit because both firms were built around the idea that capital should help shape the future, not simply chase market trends.
“She’s called Future Positive Capital and we are 2050, but our motto is to craft a fertile future,” said Ekeland. “When you invest, you’re not predicting the future, you’re shaping the future, and you deliberately say the future you want to live in and invest for that.”
2050’s evergreen structure allows it to back companies over longer timeframes than the standard venture fund cycle. Ekeland said that matters for Future Positive Capital’s portfolio, where the next task is less about new investments and more about supporting maturing companies through growth and liquidity.
“The multistage part is a big one,” she said. “Now the challenges are how do you support more growth companies and build the exits.”
Standout companies in the portfolio include Aerones, the Latvian robotics company servicing wind turbines; Upway, the electric bike refurbisher; Conceivable Life Sciences, which is building AI-powered automated IVF clinics; French elderly care company WeHealth; and fertility app Clue.
Ekeland said the Future Positive portfolio sits across energy, circular economy, digital health and medical technology. “Aerones in Latvia… is a pretty fast-growing company doing super well,” she said. “Upway… is performing pretty well. And then on the health side there’s a lot around digital health.”
Although done for personal reasons, the deal lands as climate and impact investing are being reframed by European investors around sovereignty, resilience and strategic industry. Ekeland said the old regulation-led climate narrative had shifted.
“People are realizing that these are actually critical industries like energy, food, cement, or the building industry,” she said. “It’s being completely rebranded as ‘sovereignty’.”
She said capital was returning to these areas because supply chains, resource scarcity and geopolitical tensions had made them strategic rather than merely ‘ESG-driven’.
“It’s going from being something that is kind of ESG or ‘regulation-pushed’, to something that is about sovereignty and strategic,” she said.
For 2050, the Future Positive transfer reinforces its pitch as a long-term platform for companies operating in the physical world. The firm is targeting a €1 billion investment platform focused on climate, healthcare and industrial transition.
